Virus collection matrix

US12411137B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12411137-B2
Application numberUS-202117336883-A
CountryUS
Kind codeB2
Filing dateJun 2, 2021
Priority dateDec 25, 2020
Publication dateSep 9, 2025
Grant dateSep 9, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a virus collection matrix, including: a porous gel or fibrous structure formed by a positively charged polymer material; and a plurality of ACE 2 receptors. The plurality of ACE 2 receptors are negatively charged, and distributed and covered on the surface of the porous gel or fibrous structure. The whole virus collection matrix is positively charged.

First claim

Opening claim text (preview).

What is claimed is: 1. A virus collection matrix for collecting target virus in air, comprising: a porous gel or fibrous structure formed by a positively charged polymer material; and a plurality of ACE 2 receptors, the plurality of ACE 2 receptors are negatively charged, and distributed and covered on a surface of the porous gel or fibrous structure, and wherein a whole of the virus collection matrix comprising the negatively charged ACE 2 receptors is positively charged. 2. The virus collection matrix according to claim 1 , wherein the polymer material is chitosan, and the porous gel or fibrous structure is formed by electrostatic force or EDC cross-linking reaction between molecules of chitosan. 3. The virus collection matrix according to claim 1 , wherein the plurality of ACE 2 receptors are connected to the porous gel or fibrous structure by electric charge attraction or chemical grafting. 4. The virus collection matrix according to claim 1 , wherein the virus collection matrix is applicable for collecting the target viruses including novel coronavirus (covid-19), SARS virus, or any other coronavirus containing spike proteins, and when the target virus passes through the virus collection matrix, the target virus is capable of being detained on the surface of the porous gel or fibrous structure. 5. The virus collection matrix according to claim 4 , wherein in response to the virus collection matrix detaining the target virus, the virus collection matrix exhibits a spectral characteristic peak of the spike proteins when being optically analyzed by a spectrometer. 6. The virus collection matrix according to claim 5 , wherein the virus collection matrix exhibits an absorption peak of ultraviolet spectrum at 280-290 nm, and an absorption peak of near infrared spectrum at 900-1400 nm. 7. The virus collection matrix according to claim 5 , wherein the virus collection matrix exhibits a concentration of resolution with respect to the spike proteins is lower than 3.5 uM when being optically analyzed. 8. The virus collection matrix according to claim 5 , wherein the virus collection matrix exhibits a concentration of resolution with respect to the spike proteins lower than 10 nM when being optically analyzed. 9. The virus collection matrix according to claim 1 , wherein the virus collection matrix is a chip or a filter material. 10. The virus collection matrix according to claim 1 , wherein the virus collection matrix is configured to be combined to other device or equipment so as to filter air, collect virus, or conduct combination thereof when air flows through. 11. The virus collection matrix according to claim 1 , wherein the porous gel or fibrous structure is formed of the polymer material through lyophilization, 3D printing, electrospinning nanofiber, cross-linking reaction, electrochemistry or spray coating. 12. The virus collection matrix according to claim 1 , wherein the virus collection matrix further includes a carrier, and the porous gel or fibrous structure is formed on the carrier. 13. The virus collection matrix according to claim 12 , wherein the carrier is a textile fiber or teflon.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12411137B2 cover?
The present invention provides a virus collection matrix, including: a porous gel or fibrous structure formed by a positively charged polymer material; and a plurality of ACE 2 receptors. The plurality of ACE 2 receptors are negatively charged, and distributed and covered on the surface of the porous gel or fibrous structure. The whole virus collection matrix is positively charged.
Who is the assignee on this patent?
National Yang Ming Chiao Tung Univ
What technology area does this patent fall under?
Primary CPC classification G01N33/566. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).